机构：[1]Carl Zeiss Vis Int GmbH, ZEISS Vis Care, Aalen, Germany[2]Hsch Aalen, Study Course Optometry, Aalen, Baden Wurttembe, Germany[3]Tianjin Eye Hosp, Optometr Ctr, Tianjin, Peoples R China[4]He Eye Specialist Hosp, Shenyang, Liaoning, Peoples R China[5]Beijing Tongren Eye Ctr, Beijing Tongren Vis Care, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[6]Univ New South Wales, Optometry & Vis Sci, Sydney, NSW, Australia[7]Eberhard Karls Univ Tubingen, Inst Ophthalm Res, Tubingen, Baden Wurttembe, Germany
第一作者机构：[1]Carl Zeiss Vis Int GmbH, ZEISS Vis Care, Aalen, Germany
推荐引用方式(GB/T 7714)：
Ohlendorf Arne,Rifai Katharina,Boeck-Maier Christina,et al.Myopia control efficacy through Emmetropic Progression Ratio:1-year of spectacle wear with cylindrical annular refractive elements (CARE)[J].INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.2024,65(7):
APA：
Ohlendorf, Arne,Rifai, Katharina,Boeck-Maier, Christina,Ungewiss, Judith,Lappe, Christian...&Wahl, Siegfried.(2024).Myopia control efficacy through Emmetropic Progression Ratio:1-year of spectacle wear with cylindrical annular refractive elements (CARE).INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE,65,(7)
MLA：
Ohlendorf, Arne,et al."Myopia control efficacy through Emmetropic Progression Ratio:1-year of spectacle wear with cylindrical annular refractive elements (CARE)".INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 65..7(2024)
